US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

2.47

-0.2100-7.84%

Volume:56.52K

Turnover:145.60K

Market Cap:3.64M

PE:-0.13

High:2.70

Open:2.63

Low:2.45

Close:2.68

Loading ...

Overview Company News Filings

60 Degrees announces findings from online survey about babesiosis disease

Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey

BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit

Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

Top Midday Gainers

MT Newswires Live

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment

MT Newswires Live

BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention With Yale School of Medicine and Yale School of Public Health

THOMSON REUTERS

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

60 Degrees Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

60 Degrees Pharmaceuticals Announces 2024 Annual Results

H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)

60 Degrees Pharmaceuticals Inc trading halted, news pending

60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESS Newswire

60 Degrees Pharmaceuticals files to sell 3.74M shares of common stock for holder

BUZZ-60 Degrees rises as FDA green lights Australian import of anti-malaria drug

60 Degrees Gets FDA Clearance to Import Antimalarial From Australia to Ensure Supply Continuity

MT Newswires Live

60 Degrees says FDA does not object to tafenoquine import plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SXTP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SXTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":2.47,"timestamp":1746126051148,"preClose":2.68,"halted":0,"volume":56523,"delay":0,"floatShares":1304946,"shares":1472891,"eps":-18.545406,"marketStatus":"Trading","change":-0.21,"latestTime":"05-01 15:01:14 EDT","open":2.63,"high":2.7,"low":2.445,"amount":145596.44263079998,"amplitude":0.095149,"askPrice":2.49,"askSize":200,"bidPrice":2.45,"bidSize":301,"shortable":3,"etf":0,"ttmEps":-18.545406,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":2.68,"preHourTrading":{"tag":"盘前","latestPrice":2.73,"preClose":2.68,"latestTime":"09:17 EDT","volume":723,"amount":1964.0801099999999,"timestamp":1746105432517},"postHourTrading":{"tag":"盘后","latestPrice":2.68,"preClose":2.68,"latestTime":"19:35 EDT","volume":361,"amount":962.06,"timestamp":1746056146127},"volumeRatio":0.414639},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SXTP\",,,,,undefined,":{"symbol":"SXTP","floatShares":1304946,"roa":"-89.67%","roe":"-181.78%","lyrEps":-18.545406,"volumeRatio":0.414639,"shares":1472891,"dividePrice":0,"high":2.7,"amplitude":0.095149,"preClose":2.68,"low":2.445,"week52Low":1.41,"pbRate":"-0.66","psRate":"5.34","week52High":35.994,"institutionHeld":0,"latestPrice":2.47,"committee":0.201597,"eps":-18.545406,"divideRate":0,"volume":56523,"delay":0,"ttmEps":-18.545406,"open":2.63,"prevYearClose":6.45,"prevWeekClose":2.95,"prevMonthClose":2.68,"prevQuarterClose":1.84,"fiveDayClose":2.93,"twentyDayClose":1.875,"sixtyDayClose":2.9849},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SXTP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529307332","title":"60 Degrees announces findings from online survey about babesiosis disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307332?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:50","pubTimestamp":1745326255,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP)announced findings that the actual burden of babesiosis in the United States may be significantly higher than Cent...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-announces-findings-from-online-survey-about-babesiosis-disease?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2529307763","title":"Babesiosis Disease Burden in United States is Substantially Higher Than Official Estimates, According to Preliminary Results of 60 Degrees Pharma Survey","url":"https://stock-news.laohu8.com/highlight/detail?id=2529307763","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529307763?lang=en_us&edition=fundamental","pubTime":"2025-04-22 20:44","pubTimestamp":1745325840,"startTime":"0","endTime":"0","summary":"In a survey representative of the general U.S. adult population, 1.26 percent of respondents – equivalent to about 3 million people – reported having received a medical diagnosis of babesiosis during their life-time; CDC data imply only about 73,000 people in that category.At the time they replied to the survey, 3.7 percent of respondents – equivalent to about 9.9 million people – reported they had been experiencing fatigue, a common symptom of babesiosis, for six months or longer.The online quantitative survey was conducted among a general adult population sample of 6,000 adults, with demographic variables  matched to U.S. census data for optimal representation of the U.S. population. Babesiosis was reported as a diagnosed medical condition experienced by 1.26 percent of respondents, implying that 3 million Americans may have experienced babesiosis . Moreover, approximately 17 percent of babesiosis patien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/babesiosis-disease-burden-united-states-124400994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTP","UBCP","SXTPW","CDC","BK4211","BK4007"],"gpt_icon":0},{"id":"2526598000","title":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2526598000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526598000?lang=en_us&edition=fundamental","pubTime":"2025-04-10 22:03","pubTimestamp":1744293838,"startTime":"0","endTime":"0","summary":"BRIEF-Geoff Dow to discuss Babesiosis at Healing Lyme SummitApril 10 (Reuters) - Dow Inc DOW.N:GEOFF DOW, PHD, INFECTIOUS DISEASE PRODUCT DEVELOPMENT EXPERT, TO DISCUSS BABESIOSIS AT HEALING LYME SUMM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUABGJDPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4090","SXTP","BK4585","BK4007","SXTPW","DOW"],"gpt_icon":0},{"id":"2526956033","title":"Why 60 Degrees Pharmaceuticals, Inc. (SXTP) Went Down On Thursday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526956033","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526956033?lang=en_us&edition=fundamental","pubTime":"2025-04-10 21:24","pubTimestamp":1744291448,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at where 60 Degrees Pharmaceuticals, Inc.  stands against other stocks that fall behind amid market optimism.Wall Street’s main indices rebounded from hefty losses on Wednesday after President Donald Trump announced that the US will pause the imposition of higher tariffs on 75 countries for 90 days.In a post on Truth Social, Trump said that more than 75 countries have called to negotiate and have not retaliated in any way.“I have authorized a 90-day PAUSE, and a substantially lowered Reciprocal Tariff during this period, of 10%, also effective immediately,” he noted.Following the announcement, the Dow Jones jumped by 7.87 percent, the S&P 500 surged by 9.52 percent, and the tech-heavy Nasdaq soared by 12.16 percent.Despite the overall market optimism, 10 companies, predominantly in the biopharmaceutical sector, registered losses amid the lack of fresh developments to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-60-degrees-pharmaceuticals-inc-132408554.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","SXTP","SXTPW"],"gpt_icon":0},{"id":"2526566242","title":"Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21","url":"https://stock-news.laohu8.com/highlight/detail?id=2526566242","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526566242?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:31","pubTimestamp":1744288260,"startTime":"0","endTime":"0","summary":"WASHINGTON, April  10, 2025  (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Deg","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059256/0/en/Geoff-Dow-PhD-Infectious-Disease-Product-Development-Expert-to-Discuss-Babesiosis-at-Healing-Lyme-Summit-April-15-21.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SMMF","BK4211","SXTP"],"gpt_icon":0},{"id":"2526841906","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2526841906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526841906?lang=en_us&edition=fundamental","pubTime":"2025-04-09 02:21","pubTimestamp":1744136475,"startTime":"0","endTime":"0","summary":"FatPipe  shares surged over 200% in their trading debut on Nasdaq Tuesday after the company priced its initial public offering of 695,656 shares at $5.75 apiece to raise about $4 million.60 Degrees Pharmaceuticals  said it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.Shares surged 64%, with intraday trading volume catapulted to over 73.8 million from a daily average of about 419,000.Price: 18.25, Change: +12.50, Percent Change: +217.30","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SXTP","BK4007","FATN"],"gpt_icon":0},{"id":"2525813635","title":"Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March","url":"https://stock-news.laohu8.com/highlight/detail?id=2525813635","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525813635?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:57","pubTimestamp":1744120644,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44685640/dow-jumps-over-1100-points-us-small-business-sentiment-falls-in-march","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QLD","SXTP","BK4173","USAW.SI","NVIW.SI","BK4233","CYCU","CVRX","NQmain","BK4539","BK4122","QID","MNQmain","BK4007","PSQ","BK4082","BK4123",".IXIC","USJW.SI","SQQQ","TSYW.SI","PCOM","XHG","NAOV","TQQQ"],"gpt_icon":1},{"id":"2525135808","title":"60 Degrees Pharmaceuticals Signs Patent License Deal to Develop Tafenoquine for Tick-Borne Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2525135808","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525135808?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:53","pubTimestamp":1744120430,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals  said Tuesday it signed a patent license deal with Yale School of Medicine and Yale School of Public Health to jointly develop and commercialize Tafenoquine for the treatment and prevention of tick-borne disease babesiosis.The deal comes after the start of collaboration between researchers from the organizations to look into the activity of tafenoquine against babesiosis, which is caused by microscopic parasites that infect red blood cells, the company said.Tafenoquine currently doesn't have US Food and Drug Administration approval for babesiosis treatment and prevention, according to the company.Shares of 60 Degrees Pharmaceuticals rose 83% in recent trading.Price: 3.43, Change: +1.64, Percent Change: +91.68","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525115890","title":"BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of Tafenoquine","url":"https://stock-news.laohu8.com/highlight/detail?id=2525115890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525115890?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:29","pubTimestamp":1744118945,"startTime":"0","endTime":"0","summary":"BRIEF-Sixty Degrees Pharmaceuticals Announces Patent License Agreement To Advance Development Of TafenoquineApril 8 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:SIXTY DEGREES PHARMACEUTICALS ANNO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525754891","title":"Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention With Yale School of Medicine and Yale School of Public Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2525754891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525754891?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:31","pubTimestamp":1744115498,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nFWN3QM1XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2525198894","title":"Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2525198894","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525198894?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:31","pubTimestamp":1744115460,"startTime":"0","endTime":"0","summary":"WASHINGTON, D.C., April  08, 2025  (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), a pharmaceutical company focused on developing new medici","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/08/3057618/0/en/Sixty-Degrees-Pharmaceuticals-Announces-Patent-License-Agreement-to-Advance-Development-of-Tafenoquine-for-Babesiosis-Treatment-and-Prevention-with-Yale-School-of-Medicine-and-Yale.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","ALT","BK4599","BK4139","BK4007","LU1878469433.USD"],"gpt_icon":0},{"id":"2523692634","title":"60 Degrees Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2523692634","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523692634?lang=en_us&edition=fundamental","pubTime":"2025-03-29 21:27","pubTimestamp":1743254840,"startTime":"0","endTime":"0","summary":"These 15 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.NasdaqCM:SXTP Earnings and Revenue Growth March 29th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.4%. Earnings per share  exceeded analyst estimates by 24%.Looking ahead, revenue is forecast to grow 52% p.a. on average during the next 3 years, compared to a 8.4% growth forecast for the Pharmaceuticals industry in the US.The company's shares are up 4.0% from a week ago.It is worth noting though that we have found 5 warning signs for 60 Degrees Pharmaceuticals (4 don't sit too well with us!) that you need to take into consideration.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/60-degrees-pharmaceuticals-full-2024-132720774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTP","SXTPW"],"gpt_icon":0},{"id":"2522352291","title":"60 Degrees Pharmaceuticals Announces 2024 Annual Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2522352291","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522352291?lang=en_us&edition=fundamental","pubTime":"2025-03-28 18:59","pubTimestamp":1743159540,"startTime":"0","endTime":"0","summary":"FY 2024 net product revenues increased 140% to $607.6 thousand.FY 2024 gross profit increased $443.8 thousand from  to $222.8 thousand.WASHINGTON, March 28, 2025  -- 60 Degrees Pharmaceuticals, Inc. , a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.Net product revenues increased 140% from $253.6 thousand for fiscal year 2023 to $607.6 thousand for fiscal year 2024; the Company credits growth from domestic commercial sales of ARAKODA.The Company achieved a gross profit of approximately $222.8 thousand in fiscal year 2024, compared to an approximate gross loss of $221 thousand in fiscal year 2023. Increased sales volume allowed the Company to overcome fixed cost of goods expense associated with the Drug Supply Chain Security Act that previously led to a gross loss.The Company commenced a randomized evaluation of tafenoquine versus placebo in hospitalized patients","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/60-degrees-pharmaceuticals-announces-2024-105900330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","SXTP","SXTPW"],"gpt_icon":0},{"id":"2514067602","title":"H.C. Wainwright Reaffirms Their Hold Rating on 60 Degrees Pharmaceuticals, Inc. (SXTP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514067602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514067602?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:18","pubTimestamp":1740482323,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Edward White maintained a Hold rating on 60 Degrees Pharmaceuticals, Inc. (SXTP – Research Report) today. The company’s sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-hold-rating-on-60-degrees-pharmaceuticals-inc-sxtp-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-hold-rating-on-60-degrees-pharmaceuticals-inc-sxtp-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP"],"gpt_icon":0},{"id":"2513724414","title":"60 Degrees Pharmaceuticals Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2513724414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513724414?lang=en_us&edition=fundamental","pubTime":"2025-02-22 08:53","pubTimestamp":1740185610,"startTime":"0","endTime":"0","summary":"19:50 EST 60 Degrees Pharmaceuticals (SXTP) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-inc-trading-halted-news-pending-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-inc-trading-halted-news-pending-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2513295856","title":"60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV","url":"https://stock-news.laohu8.com/highlight/detail?id=2513295856","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513295856?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:00","pubTimestamp":1740146400,"startTime":"0","endTime":"0","summary":"ORLANDO, FL / ACCESS Newswire / February 21, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc.  and Fathom Holdings Inc.  on the RedChip Small Stocks, Big Money show, a sponsored program on Bloomberg TV this Saturday, February 22, at 7 p.m. Eastern Time . Bloomberg TV is available in an estimated 73 million homes across the U.S.60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases that affect the lives of millions of people. 60 Degrees Pharmaceuticals, Inc. achieved FDA approval of its lead product, ARAKODA , for malaria prevention, in 2018. 60 Degrees Pharmaceuticals, Inc. also collaborates with prominent research organizations in the U.S., Australia, and Singapore. The 60 Degrees Pharmaceuticals, Inc. mission has been supported through in-kind funding from the U.S. Department of Defense and private institutional investors including Knight Therape","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/60-degrees-pharmaceuticals-fathom-holdings-140000195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SXTP","BK4079","AIRI","BK4144","BK4581","03160","BK4099","TM","BK4561","BK4585","BK4588","BK4100","FTHM","BK4590","BK4604","BK4555","ET","TV","SXTPW","BK4187"],"gpt_icon":0},{"id":"2511610280","title":"60 Degrees Pharmaceuticals files to sell 3.74M shares of common stock for holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2511610280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511610280?lang=en_us&edition=fundamental","pubTime":"2025-02-15 05:40","pubTimestamp":1739569212,"startTime":"0","endTime":"0","summary":"16:40 EST 60 Degrees Pharmaceuticals (SXTP) files to sell 3.74M shares of common stock for holder Published first on TheFly – the ultimate source f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-files-to-sell-3-74m-shares-of-common-stock-for-holder?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-files-to-sell-3-74m-shares-of-common-stock-for-holder?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2510135640","title":"BUZZ-60 Degrees rises as FDA green lights Australian import of anti-malaria drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2510135640","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510135640?lang=en_us&edition=fundamental","pubTime":"2025-02-12 03:29","pubTimestamp":1739302184,"startTime":"0","endTime":"0","summary":"BUZZ-60 Degrees rises as FDA green lights Australian import of anti-malaria drug** Specialty pharma firm 60 Degrees Pharmaceuticals' SXTP.O shares rise 5.6% to 63 cents in afternoon trade** Company sa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL4N3P21LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","SXTP","LU0170899867.USD","LU2237438978.USD","BK4588","USB","BK4007","BK4207","BK4504","BK4585","BK4559"],"gpt_icon":0},{"id":"2510353330","title":"60 Degrees Gets FDA Clearance to Import Antimalarial From Australia to Ensure Supply Continuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2510353330","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510353330?lang=en_us&edition=fundamental","pubTime":"2025-02-12 02:27","pubTimestamp":1739298441,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals  said Tuesday that the US Food and Drug Administration has no objections to its plan to import Kodatef, or tafenoquine, from Australia as a one-time precautionary measure to prevent potential short-term disruptions in the supply of Arakoda.Both medications are identical antimalarials for the prophylaxis of malaria in adults 18 years and older, with Arakoda as the US brand and Kodatef as its Australian counterpart.The company said it will import a five-month supply of Kodatef, while expanding Arakoda production to ensure uninterrupted tafenoquine availability for malaria prophylaxis to healthcare providers.60 Degrees shares were up more than 6% in recent trading.Price: 0.65, Change: +0.04, Percent Change: +6.49","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XJO.AU","SXTP","XKO.AU","BK4007"],"gpt_icon":0},{"id":"2510358557","title":"60 Degrees says FDA does not object to tafenoquine import plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2510358557","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510358557?lang=en_us&edition=fundamental","pubTime":"2025-02-12 02:05","pubTimestamp":1739297129,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced that the United States Food and Drug Administration does not object to the company’s plan to import Kod...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-says-fda-does-not-object-to-tafenoquine-import-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-says-fda-does-not-object-to-tafenoquine-import-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SXTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-24","symbol":"SXTP","defaultRemindTime":1740407400000,"type":"split","dateTimestamp":1740373200000,"forFactor":5,"toFactor":1,"ratio":5},{"market":"US","date":"2024-08-12","symbol":"SXTP","defaultRemindTime":1723469400000,"type":"split","dateTimestamp":1723435200000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SXTP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SXTP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1697860800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SXTP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SXTP","date":"2025-04-30","current":-0.472609,"percent":0.745921,"low":-5.827686,"twenty":-1.550549,"median":-0.896948,"eighty":-0.39944,"high":-0.148542,"avg":-1.206766,"sd":1.13565,"marketCap":3755872},"quantilePoints":[{"date":"2023-07-14","current":-3.206044,"twenty":-3.575483,"median":-3.312205,"eighty":-3.248508,"marketCap":25229961},{"date":"2023-07-21","current":-2.066589,"twenty":-3.269741,"median":-2.519541,"eighty":-2.109053,"marketCap":16263021},{"date":"2023-07-28","current":-1.549942,"twenty":-3.005047,"median":-2.066589,"eighty":-1.612223,"marketCap":12197266},{"date":"2023-08-04","current":-1.436704,"twenty":-2.556343,"median":-1.68795,"eighty":-1.51314,"marketCap":11306141},{"date":"2023-08-11","current":-1.082836,"twenty":-2.270417,"median":-1.578251,"eighty":-1.364515,"marketCap":8521377},{"date":"2023-08-18","current":-1.132378,"twenty":-2.130285,"median":-1.514555,"eighty":-1.186166,"marketCap":8911244},{"date":"2023-08-25","current":-1.075759,"twenty":-1.995815,"median":-1.493323,"eighty":-1.119638,"marketCap":8465682},{"date":"2023-09-01","current":-0.896195,"twenty":-1.818881,"median":-1.298696,"eighty":-1.075759,"marketCap":8118769},{"date":"2023-09-08","current":-0.774624,"twenty":-1.702813,"median":-1.231461,"eighty":-0.96014,"marketCap":7017437},{"date":"2023-09-15","current":-0.729811,"twenty":-1.64761,"median":-1.146532,"eighty":-0.891125,"marketCap":6611469},{"date":"2023-09-22","current":-0.512148,"twenty":-1.583913,"median":-1.121762,"eighty":-0.799591,"marketCap":4639628},{"date":"2023-09-29","current":-0.473737,"twenty":-1.572589,"median":-1.082836,"eighty":-0.74506,"marketCap":4291655},{"date":"2023-10-06","current":-0.428924,"twenty":-1.54428,"median":-1.043911,"eighty":-0.582824,"marketCap":3885688},{"date":"2023-10-13","current":-0.449858,"twenty":-1.518801,"median":-0.952467,"eighty":-0.507026,"marketCap":4075333},{"date":"2023-10-20","current":-0.524952,"twenty":-1.507478,"median":-0.898787,"eighty":-0.48823,"marketCap":4755618},{"date":"2023-10-27","current":-0.423162,"twenty":-1.507478,"median":-0.893026,"eighty":-0.483288,"marketCap":3833492},{"date":"2023-11-03","current":-0.377709,"twenty":-1.498985,"median":-0.86425,"eighty":-0.474121,"marketCap":3421725},{"date":"2023-11-10","current":-0.384111,"twenty":-1.459352,"median":-0.781026,"eighty":-0.464774,"marketCap":3479721},{"date":"2023-11-17","current":-0.435326,"twenty":-1.364515,"median":-0.768158,"eighty":-0.451894,"marketCap":3943683},{"date":"2023-11-24","current":-0.957437,"twenty":-1.302234,"median":-0.768222,"eighty":-0.451215,"marketCap":3282536},{"date":"2023-12-01","current":-1.048783,"twenty":-1.272509,"median":-0.817837,"eighty":-0.455018,"marketCap":3595711},{"date":"2023-12-08","current":-1.126596,"twenty":-1.237122,"median":-0.883455,"eighty":-0.458974,"marketCap":3862490},{"date":"2023-12-15","current":-1.209483,"twenty":-1.239655,"median":-0.898787,"eighty":-0.463494,"marketCap":4146667},{"date":"2023-12-22","current":-1.860743,"twenty":-1.313345,"median":-0.952467,"eighty":-0.469896,"marketCap":6379488},{"date":"2023-12-29","current":-1.877659,"twenty":-1.436704,"median":-0.957437,"eighty":-0.473737,"marketCap":6437483},{"date":"2024-01-05","current":-1.843828,"twenty":-1.498985,"median":-0.99083,"eighty":-0.473737,"marketCap":6321493},{"date":"2024-01-12","current":-1.684903,"twenty":-1.535158,"median":-1.005049,"eighty":-0.473737,"marketCap":5776626},{"date":"2024-01-19","current":-1.239932,"twenty":-1.578554,"median":-1.044215,"eighty":-0.473993,"marketCap":4251059},{"date":"2024-01-26","current":-0.829046,"twenty":-1.566927,"median":-1.048783,"eighty":-0.474761,"marketCap":2842352},{"date":"2024-02-02","current":-0.925149,"twenty":-1.540086,"median":-1.013507,"eighty":-0.475465,"marketCap":3171838},{"date":"2024-02-09","current":-0.910618,"twenty":-1.523834,"median":-0.998035,"eighty":-0.47745,"marketCap":3122019},{"date":"2024-02-16","current":-1.032034,"twenty":-1.51597,"median":-0.998035,"eighty":-0.482239,"marketCap":3538288},{"date":"2024-02-23","current":-0.952597,"twenty":-1.507478,"median":-0.999534,"eighty":-0.485478,"marketCap":3265942},{"date":"2024-03-01","current":-0.872837,"twenty":-1.504647,"median":-0.997482,"eighty":-0.487014,"marketCap":2992488},{"date":"2024-03-08","current":-0.96067,"twenty":-1.485273,"median":-0.987859,"eighty":-0.492942,"marketCap":3293619},{"date":"2024-03-15","current":-0.79114,"twenty":-1.449798,"median":-0.959539,"eighty":-0.498115,"marketCap":2712392},{"date":"2024-03-22","current":-0.916107,"twenty":-1.420017,"median":-0.955017,"eighty":-0.500624,"marketCap":3140839},{"date":"2024-03-28","current":-0.855077,"twenty":-1.353268,"median":-0.952532,"eighty":-0.505746,"marketCap":2931598},{"date":"2024-04-05","current":-0.849647,"twenty":-1.338044,"median":-0.936451,"eighty":-0.512148,"marketCap":3199516},{"date":"2024-04-12","current":-0.816395,"twenty":-1.316389,"median":-0.933222,"eighty":-0.524952,"marketCap":3074302},{"date":"2024-04-19","current":-0.757247,"twenty":-1.308779,"median":-0.92967,"eighty":-0.530713,"marketCap":2851568},{"date":"2024-04-26","current":-0.717764,"twenty":-1.281002,"median":-0.922727,"eighty":-0.537755,"marketCap":2702887},{"date":"2024-05-03","current":-0.712848,"twenty":-1.27038,"median":-0.915462,"eighty":-0.550879,"marketCap":2684374},{"date":"2024-05-10","current":-0.706703,"twenty":-1.25977,"median":-0.903415,"eighty":-0.619133,"marketCap":2661232},{"date":"2024-05-17","current":-3.509711,"twenty":-1.27038,"median":-0.90138,"eighty":-0.641256,"marketCap":2580238},{"date":"2024-05-24","current":-4.594449,"twenty":-1.338044,"median":-0.91304,"eighty":-0.64525,"marketCap":3377706},{"date":"2024-05-31","current":-4.661966,"twenty":-1.461121,"median":-0.918206,"eighty":-0.666636,"marketCap":3427342},{"date":"2024-06-07","current":-5.728069,"twenty":-1.522366,"median":-0.927087,"eighty":-0.675178,"marketCap":4211110},{"date":"2024-06-14","current":-4.678752,"twenty":-1.578453,"median":-0.931607,"eighty":-0.675977,"marketCap":3439683},{"date":"2024-06-21","current":-4.565851,"twenty":-1.664999,"median":-0.933222,"eighty":-0.682122,"marketCap":3356681},{"date":"2024-06-28","current":-4.459591,"twenty":-1.683685,"median":-0.93467,"eighty":-0.688267,"marketCap":3278562},{"date":"2024-07-05","current":-3.848597,"twenty":-1.749099,"median":-0.942586,"eighty":-0.700189,"marketCap":2829377},{"date":"2024-07-12","current":-4.084361,"twenty":-1.843828,"median":-0.952597,"eighty":-0.706457,"marketCap":3002704},{"date":"2024-07-15","current":-4.07606,"twenty":-1.847211,"median":-0.952597,"eighty":-0.70658,"marketCap":2996601},{"date":"2024-08-02","current":-2.282925,"twenty":-1.860743,"median":-0.955017,"eighty":-0.706703,"marketCap":1678340},{"date":"2024-08-09","current":-1.534126,"twenty":-1.877659,"median":-0.959539,"eighty":-0.710605,"marketCap":1127845},{"date":"2024-08-16","current":-1.068072,"twenty":-1.877659,"median":-0.987859,"eighty":-0.712848,"marketCap":1678338},{"date":"2024-08-23","current":-2.160665,"twenty":-1.877659,"median":-0.997482,"eighty":-0.717764,"marketCap":3395207},{"date":"2024-08-30","current":-1.710527,"twenty":-1.890582,"median":-0.999534,"eighty":-0.729811,"marketCap":2687872},{"date":"2024-09-06","current":-1.620499,"twenty":-1.88984,"median":-1.0072,"eighty":-0.729811,"marketCap":2546405},{"date":"2024-09-13","current":-1.530471,"twenty":-1.880058,"median":-1.014951,"eighty":-0.730006,"marketCap":2404938},{"date":"2024-09-20","current":-1.521468,"twenty":-1.877659,"median":-1.04133,"eighty":-0.731038,"marketCap":2390791},{"date":"2024-09-27","current":-1.468799,"twenty":-1.869809,"median":-1.049471,"eighty":-0.737686,"marketCap":2308028},{"date":"2024-10-04","current":-1.255991,"twenty":-1.862164,"median":-1.066844,"eighty":-0.740259,"marketCap":1973628},{"date":"2024-10-11","current":-1.244142,"twenty":-1.847211,"median":-1.075002,"eighty":-0.740502,"marketCap":1955009},{"date":"2024-10-18","current":-1.232293,"twenty":-1.843828,"median":-1.079298,"eighty":-0.743697,"marketCap":1936390},{"date":"2024-10-25","current":-1.016642,"twenty":-1.840904,"median":-1.082836,"eighty":-0.754697,"marketCap":1597522},{"date":"2024-10-31","current":-0.975171,"twenty":-1.832216,"median":-1.075759,"eighty":-0.763051,"marketCap":1532355},{"date":"2024-11-08","current":-1.26784,"twenty":-1.806613,"median":-1.075381,"eighty":-0.767663,"marketCap":1992247},{"date":"2024-11-15","current":-1.125653,"twenty":-1.78406,"median":-1.082836,"eighty":-0.768196,"marketCap":1768818},{"date":"2024-11-22","current":-0.205615,"twenty":-1.766768,"median":-1.075381,"eighty":-0.742898,"marketCap":1627312},{"date":"2024-11-29","current":-0.307708,"twenty":-1.757765,"median":-1.071273,"eighty":-0.734485,"marketCap":2435312},{"date":"2024-12-06","current":-0.345446,"twenty":-1.750257,"median":-1.065617,"eighty":-0.722583,"marketCap":2733983},{"date":"2024-12-13","current":-0.47898,"twenty":-1.738613,"median":-1.055566,"eighty":-0.706334,"marketCap":3790817},{"date":"2024-12-20","current":-0.40931,"twenty":-1.727188,"median":-1.048783,"eighty":-0.67358,"marketCap":3239425},{"date":"2024-12-27","current":-0.38899,"twenty":-1.717281,"median":-1.039648,"eighty":-0.641313,"marketCap":3078603},{"date":"2025-01-03","current":-0.380281,"twenty":-1.712721,"median":-1.016642,"eighty":-0.550879,"marketCap":3009679},{"date":"2025-01-10","current":-0.316417,"twenty":-1.710966,"median":-1.012063,"eighty":-0.522391,"marketCap":2504236},{"date":"2025-01-17","current":-0.239606,"twenty":-1.690028,"median":-1.00281,"eighty":-0.496592,"marketCap":1896327},{"date":"2025-01-24","current":-0.255137,"twenty":-1.68399,"median":-0.998035,"eighty":-0.483288,"marketCap":2019241},{"date":"2025-01-31","current":-0.232233,"twenty":-1.673079,"median":-0.992315,"eighty":-0.474953,"marketCap":1837972},{"date":"2025-02-07","current":-0.153564,"twenty":-1.664392,"median":-0.980029,"eighty":-0.471176,"marketCap":1215358},{"date":"2025-02-14","current":-0.582606,"twenty":-1.637571,"median":-0.96067,"eighty":-0.473737,"marketCap":4610947},{"date":"2025-02-21","current":-0.439583,"twenty":-1.620499,"median":-0.957437,"eighty":-0.473737,"marketCap":3479015},{"date":"2025-02-28","current":-0.349879,"twenty":-1.606995,"median":-0.952597,"eighty":-0.455018,"marketCap":2769070},{"date":"2025-03-07","current":-0.295909,"twenty":-1.586175,"median":-0.942586,"eighty":-0.438837,"marketCap":2341926},{"date":"2025-03-14","current":-0.325686,"twenty":-1.5827,"median":-0.933946,"eighty":-0.428924,"marketCap":2577592},{"date":"2025-03-21","current":-0.36849,"twenty":-1.578554,"median":-0.931607,"eighty":-0.419612,"marketCap":2916361},{"date":"2025-03-28","current":-0.338713,"twenty":-1.572643,"median":-0.927312,"eighty":-0.40931,"marketCap":2680696},{"date":"2025-04-04","current":-0.34102,"twenty":-1.562151,"median":-0.925149,"eighty":-0.394645,"marketCap":2710119},{"date":"2025-04-11","current":-0.574544,"twenty":-1.556789,"median":-0.915785,"eighty":-0.39251,"marketCap":4565962},{"date":"2025-04-17","current":-0.587517,"twenty":-1.553338,"median":-0.908035,"eighty":-0.394595,"marketCap":4669064},{"date":"2025-04-25","current":-0.543037,"twenty":-1.552371,"median":-0.898993,"eighty":-0.395957,"marketCap":4315570},{"date":"2025-04-30","current":-0.472609,"twenty":-1.550549,"median":-0.896948,"eighty":-0.39944,"marketCap":3755872}],"updateTime":1746126074910}}}